Boston expands drug delivery with Quanam purchase
This article was originally published in Clinica
Boston Scientific is to buy Quanam Medical, a private company that develops drug-delivery stent systems, for an undisclosed amount. Santa Clara, California-based Quanam's product uses polymers, which include active ingredients, with a proprietary stent. Drugs can be delivered directly to a lesion site.